• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Schroder UK Equity Fund Z Accumulation

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Schroder Unit Trusts Limited
Fund Summary The Fund aims to provide capital growth and income in excess of the FTSE All Share (Gross Total Return) index (after fees have been deducted) over a three to five year period by investing in equity and equity related securities of UK companies.
SEDOL code B3VQSZ8
ISIN GB00B3VQSZ80
Fund code SCEAZ
Managers Alex Breese
Manager Tenure 7 years
Morningstar Category UK Large-Cap Equity
IMA Sector UK All Companies
Fund Size £322 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.91%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.7117
Buy Price £0.7117
Price Change +1.2952%
Price Date 13th July 2020
Yield 4.57%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 3rd December 2012
Fund Status OPEN
Alex Breese is a UK Equity Fund Manager at Schroders, responsible for managing the Schroder UK Equity Fund and ISF UK Equity Funds. He joined Schroders in 2013 and is based in London. Alex was a Fund Manager, Head of UK Equities and Investment Director at Neptune Investment Management from 2005 to 2013, managing the Neptune UK Special Situations Fund from 2006. Alex was also Assistant Fund Manager of the Neptune Income and Neptune Quarterly Income Funds. He joined Neptune as an investment analyst in 2005. Prior to joining Neptune, Alex gained nearly three years experience as an engineering consultant Qualifications: CFA Charterholder; MEng in Mechanical Engineering from Cardiff University.

3-year Mean Monthly Return: -0.497%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance -19.94% -5.71% +5.96% +22.58% -4.05% +7.84% +15.87% +24.54% -5.04% +26.90%
Benchmark Performance
(UK Large-Cap Equity)
-12.42% -0.54% +7.78% +19.70% -1.91%
Time Period Cumulative Benchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day 1.30% -17.76% +19.05%
1 week -2.40% +0.47% -2.87%
1 month -1.28% +7.99% -9.27%
3 months 4.10% -18.06% +22.16%
6 months -26.72% -13.79% -12.93%
1 year -22.43% -2.46% -19.97%
3 years -7.59% +1.45% -9.04%
5 years -1.89% +6.00% -7.90%
10 years 5.05% +6.50% -1.45%
YTD -26.33% -1.59% -24.73%
Since inception Currently unavailable Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
GlaxoSmithKline PLC GBR 6.96%
Tesco PLC GBR 6.69%
BP PLC GBR 5.57%
Standard Chartered PLC GBR 4.34%
Sanofi SA FRA 4.07%
Anglo American PLC GBR 3.82%
Imperial Brands PLC GBR 3.75%
QinetiQ Group PLC GBR 3.72%
Aviva PLC GBR 3.64%
Pearson PLC GBR 3.17%
Dividend Date Per share amount Reinvestment Price
22nd June 2020 0.0104 £0.7308
23rd December 2019 0.0144 £0.9748
21st June 2019 0.0178 £0.9051
21st December 2018 0.0127 £0.8401
21st June 2018 0.0144 £0.9540
21st December 2017 0.0101 £0.9054